FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 287 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR First-Line Treatment with Ribociclib plus Letrozole Shows a Significant Overall Survival... March 22, 2022 What to Say to Someone With Cancer: A Patient Perspective July 14, 2022 COVID-19 vaccine and cancer – latest updates November 20, 2020 India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration February 7, 2024 Load more HOT NEWS Risk Tool Predicts Severe Chemotherapy Toxicity in Elderly Patients with Early... Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy... Five Questions With…Amber. Hormone Therapy for Prostate Cancer? A Genetic Test Could Help Decide
